Mr. Robert C Suhovecky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1210 Sugar Creek Sq, Fenton, MO 63026 Phone: 636-326-5113 |
Brian James Voss Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 512 Deer Pointe Ct, Fenton, MO 63026 Phone: 314-809-5111 |
Mark Froidl Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Bowles Ave, Fenton, MO 63026 Phone: 636-343-0754 |
Dr. Sara K Rumpel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2058 Fenton Logistics Park, Fenton, MO 63026 Phone: 877-273-1777 |
Mahdee Shawahin Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1210 Sugar Creek Sq, Fenton, MO 63026 Phone: 636-326-5113 |
Dr. Erica Lynn Schaeffer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 Gravois Bluffs Blvd, Fenton, MO 63026 Phone: 636-343-8402 |
Catherine Bundschuh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Bowles Ave, Fenton, MO 63026 Phone: 636-343-0754 |
Janice S Ceriotti Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1617 Manufacturers Dr, Fenton, MO 63026 Phone: 314-690-4500 Fax: 314-690-4502 |
Andrew David Biekert, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1617 Manufacturers Dr, Fenton, MO 63026 Phone: 314-690-4500 |
Amira Rajih Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Bowles Ave, Fenton, MO 63026 Phone: 636-343-0754 |
Dr. Anthony Robert Williams, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1051 Fenton Park Dr, Fenton, MO 63026 Phone: 314-401-6912 |
Pearl Shih, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1617 Manufacturers Dr, Fenton, MO 63026 Phone: 314-690-4500 |
Melia Burns, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 636-496-3761 |
Dr. Abigail Marie Scarpellini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 Old Smizer Mill Rd, Fenton, MO 63026 Phone: 636-349-2666 |
Melissa Ann Stutz, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 45 Gravois Bluffs Plaza Dr, Fenton, MO 63026 Phone: 636-343-5488 |
Mrs. Mary Ann L Anderson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 197 Gravois Bluffs Plaza Dr, T1314, Fenton, MO 63026 Phone: 636-326-7508 |
Dr. Paige Cathleen Hagen, PHARMD Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 1015 Bowles Ave, Fenton, MO 63026 Phone: 636-496-2680 |
Dr. Kristina S Park, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 653 Gravois Bluffs Blvd, Fenton, MO 63026 Phone: 636-349-3007 |
Mark A Greaves, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 450 Old Smizer Mill Rd, Fenton, MO 63026 Phone: 636-349-2666 Fax: 636-530-3018 |
Mr. Timothy W Lakebrink, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Bowles Ave, Fenton, MO 63026 Phone: 636-343-0754 |
News Archive
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has submitted a Pediatric Investigation Plan (PIP) to the European Medicines Agency (EMEA) as part of the required filing process for approval of pixantrone for treating relapsed or refractory, aggressive non-Hodgkin's Lymphoma (NHL) in Europe. The PIP outlines how the company proposes to study the drug in children in order to benefit child health.
Obesity and smoking are important risk factors for many age-related diseases. Tim Spector (St. Thomas' Hospital, UK) and colleagues in the USA looked for evidence of ageing at a molecular level in smokers and obese individuals.
Recommendations of the Neuromodulation Appropriateness Consensus Committee (NACC), announced at the 11th World Congress of the International Neuromodulation Society (INS), address established therapies and preview emerging and potential future advances.
The first commercially available treatment in the United States for patients with late-onset Pompe disease was administered today (Wednesday, June 16) at the University of Florida.
Researchers at Wake Forest University have uncovered evidence that the abnormal "editing" of gene messages in a type of white blood cell may be behind the development of lupus. Scientists hope the finding will lead to earlier diagnosis, a way to monitor patients' response to therapy and possibly a new way to treat the disease.
› Verified 7 days ago